(Q53182179)

2 July 2019

title

Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers. (English)

1 reference

2 July 2019

6

Steven A Rosenberg

1 reference

2 July 2019

author name string

Tristen S Park

1

1 reference

2 July 2019

Eric M Groh

2

1 reference

2 July 2019

Krishna Patel

3

1 reference

2 July 2019

Sid P Kerkar

4

1 reference

2 July 2019

Chyi-Chia Richard Lee

5

1 reference

2 July 2019

publication date

1 January 2016

1 reference

2 July 2019

published in

Journal of Immunotherapy

1 reference

2 July 2019

volume

39

1 reference

2 July 2019

issue

1

1 reference

2 July 2019

page(s)

1-7

1 reference

2 July 2019

MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma

cites work

1 reference

12 December 2020

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

1 reference

12 December 2020

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade

1 reference

12 December 2020

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

1 reference

12 December 2020

MAGE-A gene expression pattern in primary breast cancer

1 reference

12 December 2020

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

1 reference

12 December 2020

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer

1 reference

12 December 2020

The cancer/testis genes: review, standardization, and commentary.

1 reference

12 December 2020

Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis

1 reference

12 December 2020

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

1 reference

12 December 2020

NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

1 reference

12 December 2020

Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants

1 reference

12 December 2020

NY-ESO-1 expression and immunogenicity in esophageal cancer.

1 reference

12 December 2020

What types of colorectal cancer overexpress the MAGE protein?

1 reference

12 December 2020

Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.

1 reference

12 December 2020

NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study

1 reference

12 December 2020

Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue

1 reference

12 December 2020

The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.

1 reference

12 December 2020

Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors

1 reference

12 December 2020

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

1 reference

12 December 2020

Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

12 December 2020

MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma

1 reference

12 December 2020

Treating cancer with genetically engineered T cells

1 reference

12 December 2020

MAGE-A family: attractive targets for cancer immunotherapy

1 reference

12 December 2020

The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.

1 reference

12 December 2020

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.

1 reference

12 December 2020

MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.

1 reference

12 December 2020

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

1 reference

12 December 2020

MAGE-A3 is highly expressed in a subset of colorectal cancer patients

1 reference

12 December 2020

Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma.

1 reference

12 December 2020

Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism

1 reference

12 December 2020

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer

1 reference

12 December 2020

Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma

1 reference

12 December 2020

Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer

1 reference

12 December 2020

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

1 reference

12 December 2020

10.1097/CJI.0000000000000101

Identifiers

DOI

1 reference

2 July 2019

PMC publication ID

6453128

1 reference

2 July 2019

PubMed publication ID

26641256

1 reference

2 July 2019